规范与标准
ENGLISH ABSTRACT
针对生育人群的携带者筛查实验室和临床实践专家共识
中国妇幼保健协会生育保健分会
作者及单位信息
·
DOI: 10.3760/cma.j.cn101441-20230829-00094
Expert consensus on laboratory and clinical practice of carrier screening for reproductive populations
Reproductive Health Branch of the Chinese Maternal and Child Health Association
Huang Hefeng
Xu Chenming
Authors Info & Affiliations
Reproductive Health Branch of the Chinese Maternal and Child Health Association
Huang Hefeng
Institute of Reproduction and Development, Fudan University, Shanghai 200001, China
Xu Chenming
Genetics Center of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200001, China
·
DOI: 10.3760/cma.j.cn101441-20230829-00094
22954
1773
0
5
25
12
PDF下载
APP内阅读
摘要

作为一项孕前/孕早期筛查技术,携带者筛查已经由最初仅针对特定人群、特定疾病发展为现如今的针对一般人群、多种疾病的筛查,在防控常染色体隐性或X连锁遗传病引起的出生缺陷方面表现出了显著的临床效用,增加了受检夫妇的生育自主权。为规范携带者筛查的实验室检测和临床实施,经中国妇幼保健协会生育保健分会专家讨论,结合我国实际情况,制定本专家共识,供临床应用参考。

携带者筛查;高通量测序技术;疾病选择;筛查策略;检测前遗传咨询;检测后遗传咨询
ABSTRACT

As a pre-pregnancy/early pregnancy screening technology, carrier screening has developed from initially targeting specific populations and diseases to targeting the general population and multiple diseases now. It has shown significant clinical efficacy in preventing and controlling birth defects caused by autosomal recessive or X-linked genetic diseases, and has increased the reproductive autonomy of couples undergoing testing. To standardize laboratory testing and clinical implementation of carrier screening, this expert consensus was developed by experts from the Reproductive Health Branch of the Chinese Maternal and Child Health Association, taking into account the actual situation in China, and is provided for clinical reference.

Carrier screening;High-throughput sequencing technology;Disease selection;Screening strategies;Pre-test genetic consultation;Post-test genetic consultation
Huang Hefeng, Institute of Reproduction and Development, Fudan University, Shanghai 200001, China, Email: nc.defudabe.nadufgfehgnauh, Tel: +86-21-54237800
Xu Chenming, Genetics Center of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200001, China, Email: mocdef.3ab616002ux_gnimnehc, Tel: +86-21-33189900*8412
引用本文

中国妇幼保健协会生育保健分会. 针对生育人群的携带者筛查实验室和临床实践专家共识[J]. 中华生殖与避孕杂志,2024,44(02):109-115.

DOI:10.3760/cma.j.cn101441-20230829-00094

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
本文评分
5 [累计2个]
出生缺陷在全球范围内都是影响人口健康水平的公共卫生问题,也是胎儿、婴幼儿死亡和先天残疾的主要原因 1。单基因遗传病是导致出生缺陷的重要原因之一。由于多数常染色体隐性与X连锁遗传病在胎儿期没有明显的异常表现,父母通常也没有相关疾病的家族史,直至生育隐性单基因遗传病患儿之后才会发现夫妻的生育高风险状态(即同时是某个常染色体隐性遗传病的携带者或女方为某个X连锁遗传病的携带者)。据估计,有2%~4%的无家族史的育龄夫妻属于生育某种隐性遗传病的高风险夫妇 2。如果在备孕期或孕早期通过检测夫妇双方携带情况,进而对其进行遗传咨询及生育选择指导,就有可能降低此类疾病的生育风险,这一过程即为携带者筛查检测。
携带者筛查最早可以追溯到20世纪70年代,早期的携带者筛查主要针对特定疾病高危人群的单一疾病的筛查,并取得了很好的防控效果。随着高通量测序技术的快速发展,携带者筛查也逐步实现了从单一疾病向多种疾病,由特定高危种族人群到泛种族普通人群的转变。自2013年以来,美国医学遗传学与基因组学学会(American College of Medical Genetics and Genomics,ACMG)、美国妇产科医师学会(American College of Obstetricians and Gynecologists,ACOG)等国际专业协会连续发布了多版指南或者声明,指导和推进多种疾病携带者筛查的临床应用 3 , 4 , 5 , 6 , 7 , 8。截至目前,虽然已有不少扩展性携带者筛查在中国人群的应用研究 9 , 10 , 11 , 12 , 13,但尚缺乏针对中国人群携带者筛查的适用人群、疾病选择、实施策略、实验室检测和遗传咨询等核心内容与关键问题的指南或者共识。为此,中国妇幼保健协会生育保健分会组织国内临床专家、辅助生殖专家、遗传学专家及实验室技术专家基于中国人群携带者筛查的临床实践研究成果,结合我国的实际情况,就开展携带者筛查的实验室检测和临床实施过程中的核心内容与关键问题形成共识意见,以促进携带者筛查技术的良性发展和规范应用。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
卫生部发布《中国出生缺陷防治报告(2012)》[J]. 中国药房, 2012,23(39):3693.
[2]
Fabiani M , Cogo F , Poli M ,et al. Technical factors to consider when developing an Expanded Carrier Screening platform[J]. Curr Opin Obstet Gynecol, 2021,33(3):178-183. DOI: 10.1097/GCO.0000000000000706 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Grody WW , Thompson BH , Gregg AR ,et al. ACMG position statement on prenatal/preconception expanded carrier screening[J]. Genet Med, 2013,15(6):482-483. DOI: 10.1038/gim.2013.47 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Edwards JG , Feldman G , Goldberg J ,et al. Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine[J]. Obstet Gynecol, 2015,125(3):653-662. DOI: 10.1097/AOG.0000000000000666 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Committee Opinion No. 690 Summary: carrier screening in the age of genomic medicine[J]. Obstet Gynecol, 2017,129(3):595-596. DOI: 10.1097/AOG.0000000000001947 .
[6]
Committee Opinion No. 691: carrier screening for genetic conditions[J]. Obstet Gynecol, 2017,129(3):e41-e55. DOI: 10.1097/AOG.0000000000001952 .
[7]
Gregg AR , Aarabi M , Klugman S ,et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)[J]. Genet Med, 2021,23(10):1793-1806. DOI: 10.1038/s41436-021-01203-z .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Sagaser KG , Malinowski J , Westerfield L ,et al. Expanded carrier screening for reproductive risk assessment: an evidence-based practice guideline from the National Society of Genetic Counselors[J]. J Genet Couns, 2023,32(3):540-557. DOI: 10.1002/jgc4.1676 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
谭丽,赵培娟,齐越凡,. 孕前扩展性携带者筛查在中国汉族育龄人群中的应用价值[J]. 中华生殖与避孕杂志, 2023,43(7):713-717. DOI: 10.3760/cma.j.cn101441-20220615-00261 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
王晓晔,范蒙洁,李锐,. 133种隐性遗传病相关基因变异在200例中国人群中的分布研究[J]. 中华生殖与避孕杂志, 2019,39(3):195-201. DOI: 10.3760/cma.j.issn.2096-2916.2019.03.005 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Xi Y , Chen G , Lei C ,et al. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology[J]. Mol Genet Genomic Med, 2020,8(9):e1340. DOI: 10.1002/mgg3.1340 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Chen SC , Zhou XY , Li SY ,et al. Carrier burden of over 300 diseases in Han Chinese identified by expanded carrier testing of 300 couples using assisted reproductive technology[J]. J Assist Reprod Genet, 2023,40(9):2157-2173. DOI: 10.1007/s10815-023-02876-y .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Zhao S , Xiang J , Fan C ,et al. Pilot study of expanded carrier screening for 11 recessive diseases in China: results from 10, 476 ethnically diverse couples[J]. Eur J Hum Genet, 2019,27(2):254-262. DOI: 10.1038/s41431-018-0253-9 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. Guidance regarding gamete and embryo donation[J]. Fertil Steril, 2021,115(6):1395-1410. DOI: 10.1016/j.fertnstert.2021.01.045 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Strande NT , Riggs ER , Buchanan AH ,et al. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource[J]. Am J Hum Genet, 2017,100(6):895-906. DOI: 10.1016/j.ajhg.2017.04.015 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Lazarin GA , Hawthorne F , Collins NS ,et al. Systematic classification of disease severity for evaluation of expanded carrier screening panels[J]. PLoS One, 2014,9(12):e114391. DOI: 10.1371/journal.pone.0114391 .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Guo MH , Gregg AR . Estimating yields of prenatal carrier screening and implications for design of expanded carrier screening panels[J]. Genet Med, 2019,21(9):1940-1947. DOI: 10.1038/s41436-019-0472-7 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Xiao Q , Lauschke VM . The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders[J]. NPJ Genom Med, 2021,6(1):41. DOI: 10.1038/s41525-021-00203-x .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Arjunan A , Torres R , Gardiner A ,et al. Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples[J]. Prenat Diagn, 2021,41(7):896-904. DOI: 10.1002/pd.5900 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Tsai GJ , Rañola J , Smith C ,et al. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance[J]. Genet Med, 2019,21(6):1435-1442. DOI: 10.1038/s41436-018-0335-7 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
孙隽,黄颐,王小冬,. 遗传病二代测序临床检测全流程规范化共识探讨(3)——数据分析流程[J]. 中华医学遗传学杂志, 2020,37(3):345-351. DOI: 10.3760/cma.j.issn.1003-9406.2020.03.021
返回引文位置Google Scholar
百度学术
万方数据
[22]
Richards S , Aziz N , Bale S ,et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015,17(5):405-424. DOI: 10.1038/gim.2015.30 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Tavtigian SV , Greenblatt MS , Harrison SM ,et al. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework[J]. Genet Med, 2018,20(9):1054-1060. DOI: 10.1038/gim.2017.210 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
邬玲仟,张学. 医学遗传学[M]. 北京:人民卫生出版社, 2016:82.
[25]
Bell CJ , Dinwiddie DL , Miller NA ,et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing[J]. Sci Transl Med, 2011,3(65):65ra4. DOI: 10.1126/scitranslmed.3001756 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Chau J , Yu M , Chui M ,et al. Comprehensive analysis of recessive carrier status using exome and genome sequencing data in 1 543 Southern Chinese[J]. NPJ Genom Med, 2022,7(1):23. DOI: 10.1038/s41525-022-00287-z .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Liao C , Mo QH , Li J ,et al. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal Hospital[J]. Prenat Diagn, 2005,25(2):163-171. DOI: 10.1002/pd.1079 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Janssens S , Chokoshvili D , Vears DF ,et al. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views[J]. BMC Med Ethics, 2017,18(1):46. DOI: 10.1186/s12910-017-0206-9 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
张芳,谭建新,邵彬彬,. 单基因隐性遗传病扩展性携带者筛查的遗传咨询[J]. 中华妇产科杂志, 2020,55(4):280-283. DOI: 10.3760/cma.j.cn112141-20191112-00615 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Strom CM , Crossley B , Redman JB ,et al. Molecular testing for Fragile X Syndrome: lessons learned from 119,232 tests performed in a clinical laboratory[J]. Genet Med, 2007,9(1):46-51. DOI: 10.1097/gim.0b013e31802d833c .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology. Recommendations for practices using gestational carriers: a committee opinion[J]. Fertil Steril, 2022,118(1):65-74. DOI: 10.1016/j.fertnstert.2022.05.001 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Chang C , Gupta AO , Orchard PJ ,et al. A case series of adrenoleukodystrophy in children conceived through in vitro fertilization with an egg donor [J]. F S Rep, 2023,4(1):24-28. DOI: 10.1016/j.xfre.2022.12.005 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Crockin S , Gibbons W . Genetic carrier screening in donors: a challenging frontier[J]. F S Rep, 2023,4(1):20-21. DOI: 10.1016/j.xfre.2023.02.003 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Xue Y , Ankala A , Wilcox WR ,et al. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing[J]. Genet Med, 2015,17(6):444-451. DOI: 10.1038/gim.2014.122 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
de Wert G , van der Hout S , Goddijn M ,et al. The ethics of preconception expanded carrier screening in patients seeking assisted reproduction[J]. Hum Reprod Open, 2021,2021(1):hoaa063. DOI: 10.1093/hropen/hoaa063 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A

黄荷凤负责论文构思、撰写及修改;徐晨明负责论文构思和撰写;陈松长、杨昀负责论文撰写及修改;共识编写专家组其他成员负责论文的修改

B
黄荷凤,复旦大学生殖发育研究院,上海 200001,Email: nc.defudabe.nadufgfehgnauh,电话:+86-21-54237800
C
徐晨明,复旦大学附属妇产科医院妇产科遗传中心,上海 200001,Email: mocdef.3ab616002ux_gnimnehc,电话:+86-21-33189900*8412
D
中国妇幼保健协会生育保健分会. 针对生育人群的携带者筛查实验室和临床实践专家共识[J]. 中华生殖与避孕杂志, 2024, 44(2): 109-115. DOI: 10.3760/cma.j.cn101441-20230829-00094.
E
所有作者均声明不存在利益冲突
F
国家重点研发计划 (2023YFC2705600,2023YFC2705601,2023YFC2705603,2021YFC2701002,2022YFC2703702)
国家自然科学基金 (81971344,82171677,82192864)
上海市自然科学基金 (23ZR1408000)
市级医院新兴前沿技术联合攻关项目-上海申康医院发展中心 (SHDC12023120)
上海市卫健委项目 (202140110)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号